Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Neurodegeneration involves the progressive loss of nerve structure and function and is a common characteristic of several conditions, including Parkinson’s, Alzheimer’s and Huntington’s. Such diseases are presently incurable.
Researchers from the University’s Institute of Translational Medicine have found that the anti-epileptic drug ethosuximide has protective effects in certain neurodegenerative disease models.
Making a difference
Professor of Cellular and Molecular Physiology, Alan Morgan, said: “Incidence of these diseases is on the rise due to our increasingly ageing population, yet there is a lack of effective therapies to treat them.
“Our research suggests that ethosuximide has potential for repurposing as a treatment for multiple neurodegenerative diseases and provides a platform from which new medicines could be developed.
“Indeed, we are now actively pursuing this in current research with colleagues Professor Bob Burgoyne and PhD student, Shi Quan Wong. Eventually, we hope that our work will make a difference to those suffering from these debilitating diseases.”
The study was funded by grants from the BBSRC, the Wellcome Trust and Age UK.
The paper ‘Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression’ was published in the journal Molecular Neurodegeneration and can be accessed here: http://bit.ly/1VAFn7v
You must be logged in to post a comment.
All recent news
Liverpool leads new national encephalitis study
Liverpool Guild of Students designated as Hate Crime Reporting Centre
Free festival explores climate change, ‘fake news’ and more
Staying safe in the city
An open letter from UUK and UCEA to staff impacted by the latest UCU pensions and pay disputes
Researchers @LivUni have been awarded £2.6 million to lead a national study looking at new treatment for autoimmune #encephalitis
Read more here👉http://bit.ly/32fe9z3
Front page of our News site this morning 📰
Researchers are leading a study looking at new treatment for autoimmune #encephalitis, an award-winning line-up for our #LivOpenHouse festival, and how oceans are moderators of #ClimateChange.
Find it all here👉https://news.liverpool.ac.uk
Front page of our📰News site this morning
Research identifies barriers to developing seawater electrolysis tech, Virtual Engineering Centre's £4m support for SMEs and Liverpool engineers presenting research to #UKParliament
Find it all here 👉https://news.liverpool.ac.uk